Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, November 17, 2010

(Halifax, NS) Immunovaccine Inc. Announces Phase I/II Clinical Plan for DPX-Survivac to Target Ovarian Cancer - MarketWatch

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.